---
figid: PMC9055624__nihms-1800788-f0002
figtitle: Twenty years of progress in angiotensin converting enzyme 2 and its link
  to SARS-CoV-2 disease
organisms:
- Severe acute respiratory syndrome coronavirus 2
- Coronaviridae
- Severe acute respiratory syndrome-related coronavirus
- Betacoronavirus
- Canis lupus familiaris
- Ovis aries
- Mustela putorius furo
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Nicotiana tabacum
- Trypanosoma cruzi
- Chamaeleo chamaeleon
organisms_ner:
- Homo sapiens
- Mus musculus
- Rattus norvegicus
- Canis lupus familiaris
- Ovis aries
- Mustela putorius furo
- Danio rerio
pmcid: PMC9055624
filename: nihms-1800788-f0002.jpg
figlink: /pmc/articles/PMC9055624/figure/F2/
number: F2
caption: 'Schematic overview of the intracellular signaling molecules mediating Ang
  II actions on vascular smooth muscle constriction (brown arrows), transcription,
  growth and protein synthesis (blue arrows) vs. the signaling pathways (green arrows)
  activated by Ang-(1–7) which limits AT1-R pathway activation through stimulation
  of antioxidant responses mediated by NO production, prostaglandin synthesis, and
  reduction in the rate of Ang II metabolism by membrane anchored ACE2Activation of
  MAP kinases ERK1/2 via the G-coupled AT1-R promotes transactivation of the EGF receptor
  and stimulation of Ras-dependent and Ras-independent pathways []. Ang-(1–7) binding
  to the Mas receptor activates endothelial NO synthase (eNOS) mediated stimulation
  of NO via a protein kinase B (Akt)-dependent pathway. Ang-(1–7) stimulates dose-dependent
  release of cAMP by prostacyclin-mediated activation of adenylate cyclase. This signaling
  pathway causes suppression of Ang II stimulation of MAP kinase activities (ERK1/2).
  Dephosphorylation of MAP kinases by Ang-(1–7)- stimulation of DUSP-1 counteracts
  Ang II-mediated agonist actions. Pathways represented in the diagram summarized
  from studies reported in references [,,,–,,,]. Abbreviations: cAMP, cyclic adenosine
  monophosphate; EGF, epidermal growth factor.'
papertitle: Twenty years of progress in angiotensin converting enzyme 2 and its link
  to SARS-CoV-2 disease.
reftext: Carlos M. Ferrario, et al. Clin Sci (Lond). ;134(19):2645-2664.
year: '2020'
doi: 10.1042/CS20200901
journal_title: 'Clinical science (London, England : 1979)'
journal_nlm_ta: Clin Sci (Lond)
publisher_name: ''
keywords: ''
automl_pathway: 0.9375953
figid_alias: PMC9055624__F2
figtype: Figure
redirect_from: /figures/PMC9055624__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9055624__nihms-1800788-f0002.html
  '@type': Dataset
  description: 'Schematic overview of the intracellular signaling molecules mediating
    Ang II actions on vascular smooth muscle constriction (brown arrows), transcription,
    growth and protein synthesis (blue arrows) vs. the signaling pathways (green arrows)
    activated by Ang-(1–7) which limits AT1-R pathway activation through stimulation
    of antioxidant responses mediated by NO production, prostaglandin synthesis, and
    reduction in the rate of Ang II metabolism by membrane anchored ACE2Activation
    of MAP kinases ERK1/2 via the G-coupled AT1-R promotes transactivation of the
    EGF receptor and stimulation of Ras-dependent and Ras-independent pathways [].
    Ang-(1–7) binding to the Mas receptor activates endothelial NO synthase (eNOS)
    mediated stimulation of NO via a protein kinase B (Akt)-dependent pathway. Ang-(1–7)
    stimulates dose-dependent release of cAMP by prostacyclin-mediated activation
    of adenylate cyclase. This signaling pathway causes suppression of Ang II stimulation
    of MAP kinase activities (ERK1/2). Dephosphorylation of MAP kinases by Ang-(1–7)-
    stimulation of DUSP-1 counteracts Ang II-mediated agonist actions. Pathways represented
    in the diagram summarized from studies reported in references [,,,–,,,]. Abbreviations:
    cAMP, cyclic adenosine monophosphate; EGF, epidermal growth factor.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EGF
  - MAP2K1
  - MAP2K2
  - MAP2K7
  - MAPK3
  - MAPK1
  - PTPN11
  - SRC
  - FGR
  - FYN
  - YES1
  - ANGPT2
  - VPS51
  - JAK2
  - GIT1
  - PLCG1
  - PLCG2
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MKNK1
  - DUSP1
  - DUSP12
  - DYNLL1
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - ACE2
  - PLA2G1B
  - PLA2G2A
  - PLA2G6
  - PLA2G3
  - PLA2G5
  - PLA2G7
  - PLA2G10
  - PLA2G12A
  - PLA2G12B
  - PLA2G2C
  - PLA2G2D
  - PLA2G2E
  - PLA2G2F
  - PLA2G4A
  - PLA2G4C
  - PLA2G4D
  - PLCB2
  - NOS3
  - ENO4
  - AKT1
  - AKT2
  - AKT3
  - Egf
  - Map2k1
  - Map2k2
  - Mdk
  - Mapk3
  - Mapk1
  - Ptpn11
  - Src
  - Agt
  - Jak2
  - Git1
  - Zhx2
  - Mknk1
  - Dusp1
  - Dynll1
  - Ace2
  - Ptgir
  - Pla2g2a
  - Pla2g5
  - Plcb2
  - Nos3
  - Akt1
  - Prkcg
  - ANG-2
  - egf
  - celsr1a
  - map2k1
  - map2k2a
  - mapk3
  - ptpn11a
  - src
  - angpt2b
  - jak2b
  - git1
  - dusp1
  - ace2
  - gpib
  - plcb2
---
